WuXi Biologics Plans Big Increase in Manufacturing Capacity
publication date: May 25, 2018
Over the past month, WuXi Biologics has announced three new manufacturing plants, two of them outside of China -- the first time it has located manufacturing plants in a foreign country. The new facilities represent substantial investments: $390 million for the Ireland plant, $240 million for Shijiazhuang (northern China) and $60 million in Singapore. WuXi completed its first biologics plant in 2012 in Wuxi City, which remained its only manufacturing facility until last year. By 2022, when all its announced facilities are expected to be GMP certified, WuXi will have ten plants operating with a total capacity of 222,700 liters annually, up from zero production capacity in 2011. More details....
Stock Symbol: (HK: 2269)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.